ArticleThe Journal of thoracic and cardiovascular surgery2023

Commentary: Neoadjuvant immune checkpoint monotherapy for lung cancer: Has the train left the station?

Nasser K Altorki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.